Sort
48,018 grants matching “immunotherapy”
PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES
$515,514Columbia University Health Sciences · R01 · FY2003 · DK
Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
$515,375Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
eDyNAmiC-TEXASSW
$515,342Zhijian J Chen · Ut Southwestern Medical Center · OT2 · FY2025 · CA
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$515,333Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2024 · CA
CAREER: A Biomanufactured Platform for Modulating Immune Cell-Bacteria Interactions in the Tumor Microenvironment
$515,223Bahareh Behkam · Virginia Polytechnic Institute And State University · · FY2015 · ENG
Regulatory and effector T cells in oral immunotherapy for food allergy
$515,197Wayne G Shreffler · Massachusetts General Hospital · U19 · FY2014 · AI
Unraveling the Pathophysiology of Neurotoxicity Induced by CAR T-cells
$515,180Christopher A Pennell · University Of Minnesota · R01 · FY2024 · CA
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$515,141Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting the gut microbiome to inhibit melanoma lymph node metastases
$515,112Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$515,103Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer
$515,091Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Project 2: The Impact of Immunotherapy on Human Vaccination
$515,006E. John Wherry · Massachusetts General Hospital · U19 · FY2020 · AI
New Materials to Deliver mRNA: Applications in Cancer Immunotherapy
$514,997Robert M. Waymouth · Stanford University · R01 · FY2023 · CA
Core--Specimen
$514,995Nancy B. Kiviat · Fred Hutchinson Cancer Research Center · P50 · FY2007 · CA
Host-Tumor Cell Interactions in Myeloma: Therapeutic Applications
$514,934Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$514,902Donald P McDonnell · Duke University · R01 · FY2024 · CA
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT) - DCC
$514,831Susanne May · University Of Washington · U01 · FY2017 · HL
Mechanisms of T Cell Memory Quiescence
$514,790Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2021 · AI
Mechanisms of T Cell Memory Quiescence
$514,790Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2022 · AI
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
$514,741Benjamin G Vincent · Univ Of North Carolina Chapel Hill · R37 · FY2023 · CA
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
$514,697Zihai Li · Cedars-Sinai Medical Center · P01 · FY2025 · CA
Lymph node-targeted multistage chemoimmunotherapy for lymphoma
$514,622Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2021 · CA
Effector T Cell Trafficking in Ovarian Cancer
$514,525Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2015 · CA